(MedPage Today) -- Positive topline results announced for FOURIER
via PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial
by
Showing posts with label PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial. Show all posts
Showing posts with label PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial. Show all posts
Thursday, February 2, 2017
Subscribe to:
Posts (Atom)